PTAB challenges

Proceedings overview

There is one AIA trial proceeding on file for US Patent 9,523,826. This proceeding, IPR2026-00093, resulted in a discretionary denial of institution, meaning no claims were adjudicated on the merits. This outcome leaves all claims of the patent untested by the PTAB.

IPR2026-00093 — Accelight Technologies, Inc. et al. v. Applied Optoelectronics, Inc.

• Type: Inter Partes Review
• Filed: 2025-11-03
• Status: Discretionary Denial (Not Instituted - Procedural). The petition was denied institution on procedural grounds without reaching the merits of the patentability challenges.
• Judge panel: Administrative Patent Judges Jennifer H. Meyer, Kevin W. Turner, and Brian J. Leitten.
• Petition grounds: Accelight Technologies, Inc. and CIG Shanghai, Co., Ltd. challenged claims 1-7 of U.S. Patent No. 9,523,826 as unpatentable under 35 U.S.C. § 103 over combinations of prior art, including US 2011/0081114 A1 (Sargent) in view of US 7,201,520 B2 (Nishimura).
• Institution decision: Denied on 2026-04-27. The Board exercised its discretion to deny institution under 35 U.S.C. § 314(a), citing the factors outlined in [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. Fintiv, Inc. and its progeny. Specifically, the Board determined that a co-pending district court litigation involving the same parties and claims weighed against institution.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: The proceeding was terminated by the discretionary denial of institution, not by settlement.
• Appeal: No appeal was filed with the Federal Circuit, as no Final Written Decision was issued.
• Defensive value: Since institution was denied on discretionary, non-merit-based grounds (specifically Fintiv), this IPR does not establish the patentability of the challenged claims. A future defendant could potentially challenge the same claims on the same or different grounds, although the Fintiv analysis might still present a hurdle if parallel district court litigation exists.

Strategic summary

All claims (1-7) of US Patent 9,523,826 remain UNTESTED by the PTAB in terms of a merits-based final written decision. The sole IPR proceeding, IPR2026-00093, filed by Accelight Technologies, Inc. et al., was denied institution. This means the PTAB did not make a determination on the patentability of any claims, and they are all considered patentable as far as the PTAB is concerned for this specific proceeding.

Regarding the estoppel landscape, since IPR2026-00093 did not proceed to a Final Written Decision, statutory estoppel under 35 U.S.C. § 315(e)(2) does not apply. This means that Accelight Technologies, Inc. (and its privies) are not barred by statute from raising any grounds that were raised or could have been reasonably raised in this IPR. However, depending on the specifics of the Fintiv denial and the parallel litigation, common law principles might still be invoked in certain circumstances, though this is less definitive than statutory estoppel. For other potential defendants, all prior-art grounds remain available for future challenges against claims 1-7.

The patent has only faced one IPR, which was denied institution, so there are no significant "pattern signals" of aggressive PTAB appeals by the patent owner or multiple IPRs by the same petitioner. The denial based on Fintiv suggests the patent owner (Applied Optoelectronics, Inc.) successfully argued for deferral to district court proceedings.

Recommended next steps

• Since institution was denied in IPR2026-00093, there are no invalidated claims to reference a Final Written Decision for. The Board's decision denying institution can be found on the PTAB End-to-End system. The denial explicitly states, "For the foregoing reasons, the Petition is DENIED as a matter of discretion under 35 U.S.C. § 314(a)."
• There are no active PTAB proceedings on US9523826 requiring tracking of trial-stage milestones.
• The absence of any PTAB activity that resulted in a merits-based decision suggests that the patent's claims have not been definitively tested for patentability by the PTAB.